Scarica l'app Stockscreener
63.50
1.23%
-0.73
Dopo l'orario di chiusura:
63.00
-0.50
-0.79%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$64.23
Aprire:
$64.23
Volume 24 ore:
1.95M
Relative Volume:
1.18
Capitalizzazione di mercato:
$7.70B
Reddito:
$12.50B
Utile/perdita netta:
$314.00M
Rapporto P/E:
26.02
EPS:
2.44
Flusso di cassa netto:
$421.00M
1 W Prestazione:
+0.30%
1M Prestazione:
-6.60%
6M Prestazione:
-1.70%
1 anno Prestazione:
-10.89%
Intervallo 1D:
$63.37
$64.83
Intervallo di 1 settimana:
$61.95
$64.83
Portata 52W:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Nome
Henry Schein Inc
Settore
Industria
Telefono
(631) 843-5500
Indirizzo
135 DURYEA RD, MELVILLE, NY
Confronta HSIC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
63.50 | 7.79B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
795.58 | 97.93B | 377.60B | 3.35B | 5.67B | 25.06 |
|
COR
Cencora Inc
|
330.84 | 63.75B | 316.65B | 1.91B | 1.14B | 9.7209 |
|
CAH
Cardinal Health Inc
|
159.51 | 37.70B | 222.58B | 1.57B | 1.85B | 6.4395 |
|
AHG
Akso Health Group Adr
|
1.54 | 895.20M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-26 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-07-25 | Downgrade | Stifel | Buy → Hold |
| 2025-07-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | Iniziato | Wells Fargo | Equal Weight |
| 2025-01-06 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-07-22 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2023-12-12 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-11-10 | Aggiornamento | Stifel | Hold → Buy |
| 2022-08-08 | Aggiornamento | UBS | Sell → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Neutral |
| 2022-06-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | Ripresa | Credit Suisse | Outperform |
| 2022-01-31 | Iniziato | Morgan Stanley | Underweight |
| 2022-01-07 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | Ripresa | Credit Suisse | Neutral |
| 2021-02-08 | Ripresa | Piper Sandler | Overweight |
| 2021-01-04 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-04-02 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2019-08-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | Iniziato | Wolfe Research | Underperform |
| 2019-05-15 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-01-17 | Iniziato | UBS | Sell |
| 2019-01-03 | Downgrade | Evercore ISI | In-line → Underperform |
| 2019-01-02 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | Reiterato | Barrington Research | Outperform |
| 2018-10-25 | Downgrade | Edward Jones | Hold → Sell |
| 2018-10-19 | Ripresa | Goldman | Neutral |
| 2018-10-04 | Reiterato | Robert W. Baird | Outperform |
| 2018-08-07 | Reiterato | Stifel | Hold |
| 2018-04-24 | Downgrade | Goldman | Buy → Neutral |
| 2018-04-04 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
Mostra tutto
Henry Schein Inc Borsa (HSIC) Ultime notizie
Henry Schein to Present at November Conferences - Dentistry Today
Henry Schein (Nasdaq: HSIC) to present at Stifel Nov 12, Jefferies Nov 18; live webcasts - Stock Titan
Henry Schein to Participate in Upcoming Investor Conferences in November - Bluefield Daily Telegraph
Will earnings trigger a reversal in Henry Schein Inc.July 2025 Reactions & Consistent Return Strategy Ideas - newser.com
Analyzing drawdowns of Henry Schein Inc. with statistical toolsMarket Weekly Review & Safe Capital Growth Trade Ideas - newser.com
Can Henry Schein Inc. recover in the next quarter2025 Top Gainers & Fast Gaining Stock Reports - newser.com
Has Henry Schein Inc. found a price floorGDP Growth & Stock Portfolio Risk Control - newser.com
Will Henry Schein Inc. bounce back from current support2025 Market Sentiment & Consistent Growth Equity Picks - newser.com
Henry Schein to Report Q3 2025 Earnings - Dentistry Today
Henry Schein to Webcast Third Quarter 2025 Conference Call on Tuesday, November 4, 2025, at 8:00 A.M. ET - BioSpace
Earnings Preview: What to Expect From Henry Schein’s Report - inkl
Why Henry Schein Inc. stock could be next big winnerTrade Entry Report & Fast Exit and Entry Trade Guides - nchmf.gov.vn
Understanding Henry Schein Inc.’s price movementLong Setup & Fast Momentum Entry Tips - newser.com
Is Henry Schein Inc. stock bottoming outTrade Risk Assessment & Daily Chart Pattern Signals - newser.com
Is Henry Schein Inc. stock dividend yield sustainableJuly 2025 Earnings & Risk Adjusted Buy and Sell Alerts - newser.com
Henry Schein, Inc. (HSIC) Stock Forecasts - Yahoo
Can Henry Schein Inc. stock hit analyst price targetsDollar Strength & Fast Gain Stock Trading Tips - newser.com
Chart based analysis of Henry Schein Inc. trendsLayoff News & Weekly Momentum Stock Picks - newser.com
Henry Schein Inc Stock Analysis and ForecastReal-Time Stock Alerts & Capitalize On Momentum - earlytimes.in
Why Henry Schein Inc. stock is trending among retail traders2025 Technical Patterns & Fast Entry Momentum Trade Alerts - nchmf.gov.vn
Gains Recap: Why Henry Schein Inc. stock is considered a top pickWeekly Earnings Recap & Free Accurate Trade Setup Notifications - nchmf.gov.vn
Henry Schein (HSIC): Evaluating Valuation After New Biomerica Deal and Analyst Downgrade - Sahm
How Henry Schein Inc. stock responds to policy changesWeekly Trend Report & Daily Risk Controlled Trade Plans - nchmf.gov.vn
Why Henry Schein Inc. stock is considered a top pickMarket Performance Summary & Free Long-Term Investment Growth Plans - nchmf.gov.vn
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
What dividend safety score for Henry Schein Inc. stockWeekly Investment Summary & Growth Focused Entry Point Reports - nchmf.gov.vn
S P Trends: What dividend safety score for Henry Schein Inc. stockMarket Sentiment Report & Community Consensus Picks - nchmf.gov.vn
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's inFoods IBS Test in the U.S. - MarketScreener
Henry Schein (HSIC) Gets a Hold from Leerink Partners - The Globe and Mail
Henry Schein Announces Record Date, Distribution Date And Anticipated When-Issued Trading Market For Spin-Off Of Animal Healt... - ADVFN
Henry Schein Announces $400 Million Increase to Share Repurchase Plan - ADVFN
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S. - ADVFN
How Biomerica Deal Expands Henry Schein’s (HSIC) Diagnostic Ambitions and Alters Its Investment Narrative - Yahoo Finance
Assessing Henry Schein (HSIC) Valuation After Recent Share Price Decline - Yahoo Finance
TAG Expands Tech With Planmeca Partnership - Dentistry Today
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's Infoods®? Ibs Test in the U.S - MarketScreener
Biomerica (BMRA) Partners with Henry Schein to Expand IBS Test R - GuruFocus
Biomerica Says Irritable Bowel Syndrome Test to be Marketed by Henry Schein in US - MarketScreener
Henry Schein and Biomerica enter into marketing services agreement for Biomerica's inFoods IBS Test in the US - MarketScreener
59.6% of treated patients hit FDA abdominal pain endpoint; Biomerica, Henry Schein to market inFoods® in U.S. (ex NY) - Stock Titan
CFRA downgrades Henry Schein (HSIC) to a Sell - The Globe and Mail
Henry Schein Inc Azioni (HSIC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.29%
4.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):